Larvol Delta - Development-and-Characterization-of-Novel-Antibodies-Targeting-Amyloid-Beta-Oligomers-with-High-Selectivity

ACU234 - Acumen Pharma

https://www.globenewswire.com/news-release/2026/03/17/3257081/0/en/Acumen-Pharmaceuticals-Presents-Studies-on-Enhanced-Brain-Delivery-Biomarker-Research-and-Novel-Antibodies-at-Advances-in-Alzheimer-s-Treatment-at-International-Conference-on-Alzhe.html

Mar 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next